Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Diseases, Cystic | 6 | 2006 | 31 | 0.800 |
Why?
|
| Kidney Neoplasms | 8 | 2007 | 206 | 0.760 |
Why?
|
| Choristoma | 2 | 2007 | 20 | 0.410 |
Why?
|
| Urethral Diseases | 2 | 2007 | 21 | 0.410 |
Why?
|
| Cysts | 3 | 2007 | 70 | 0.400 |
Why?
|
| Tomography, X-Ray Computed | 16 | 2008 | 2324 | 0.370 |
Why?
|
| Diagnostic Imaging | 3 | 1998 | 201 | 0.360 |
Why?
|
| Polycystic Kidney Diseases | 3 | 1995 | 39 | 0.340 |
Why?
|
| Urinary Bladder Diseases | 2 | 2007 | 26 | 0.300 |
Why?
|
| Rare Diseases | 1 | 2007 | 41 | 0.280 |
Why?
|
| Cervix Uteri | 1 | 2007 | 64 | 0.280 |
Why?
|
| Adrenal Gland Neoplasms | 3 | 1995 | 26 | 0.260 |
Why?
|
| Carcinoma, Renal Cell | 4 | 2007 | 110 | 0.220 |
Why?
|
| Kidney | 2 | 1997 | 945 | 0.190 |
Why?
|
| Pregnancy, Tubal | 1 | 1999 | 5 | 0.170 |
Why?
|
| Myelolipoma | 2 | 1995 | 3 | 0.160 |
Why?
|
| Pancreatic Cyst | 1 | 1996 | 16 | 0.140 |
Why?
|
| Diagnosis, Differential | 7 | 2006 | 1140 | 0.140 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 1996 | 22 | 0.140 |
Why?
|
| Radiology | 2 | 2015 | 97 | 0.140 |
Why?
|
| Splenic Neoplasms | 1 | 1995 | 5 | 0.130 |
Why?
|
| Splenic Diseases | 1 | 1995 | 10 | 0.130 |
Why?
|
| Adrenal Glands | 1 | 1995 | 46 | 0.130 |
Why?
|
| High Fidelity Simulation Training | 1 | 2015 | 6 | 0.130 |
Why?
|
| Pancreas Transplantation | 1 | 1995 | 71 | 0.120 |
Why?
|
| Humans | 32 | 2015 | 68618 | 0.120 |
Why?
|
| Pheochromocytoma | 1 | 1993 | 22 | 0.120 |
Why?
|
| Contrast Media | 2 | 2015 | 595 | 0.110 |
Why?
|
| Urologic Neoplasms | 1 | 1993 | 14 | 0.110 |
Why?
|
| Middle Aged | 16 | 2008 | 21147 | 0.110 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1993 | 36 | 0.110 |
Why?
|
| Adenoma | 2 | 1995 | 132 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 1996 | 332 | 0.110 |
Why?
|
| Orofaciodigital Syndromes | 1 | 1992 | 4 | 0.100 |
Why?
|
| Female | 18 | 2007 | 38074 | 0.100 |
Why?
|
| Adipose Tissue | 2 | 1990 | 221 | 0.100 |
Why?
|
| Male | 21 | 2010 | 37321 | 0.090 |
Why?
|
| Curriculum | 1 | 2015 | 575 | 0.090 |
Why?
|
| Iohexol | 1 | 1991 | 82 | 0.090 |
Why?
|
| Prostatic Diseases | 1 | 2010 | 5 | 0.090 |
Why?
|
| Urination Disorders | 1 | 2010 | 20 | 0.090 |
Why?
|
| Adult | 13 | 2008 | 21403 | 0.090 |
Why?
|
| Lipoma | 1 | 1990 | 24 | 0.090 |
Why?
|
| Liver Diseases | 1 | 1992 | 193 | 0.090 |
Why?
|
| Hemangioma | 1 | 1990 | 51 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2015 | 596 | 0.080 |
Why?
|
| Gigantism | 1 | 1988 | 2 | 0.080 |
Why?
|
| Foot Deformities, Congenital | 1 | 1988 | 4 | 0.080 |
Why?
|
| Aged | 11 | 2007 | 14862 | 0.080 |
Why?
|
| Multiple Trauma | 1 | 2008 | 50 | 0.080 |
Why?
|
| Toes | 1 | 1988 | 27 | 0.080 |
Why?
|
| Thoracic Injuries | 1 | 2008 | 44 | 0.080 |
Why?
|
| Leiomyosarcoma | 1 | 2007 | 17 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2007 | 2223 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 1995 | 1615 | 0.070 |
Why?
|
| Kidney Transplantation | 1 | 1995 | 839 | 0.070 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2007 | 14 | 0.070 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2007 | 46 | 0.070 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2006 | 7 | 0.070 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2007 | 138 | 0.070 |
Why?
|
| Pulmonary Embolism | 1 | 2008 | 253 | 0.070 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2006 | 81 | 0.070 |
Why?
|
| Positron-Emission Tomography | 1 | 2006 | 160 | 0.060 |
Why?
|
| Vascular Neoplasms | 1 | 2004 | 15 | 0.060 |
Why?
|
| Vena Cava, Inferior | 1 | 2004 | 41 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 468 | 0.060 |
Why?
|
| Biopsy | 2 | 1996 | 540 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2007 | 375 | 0.050 |
Why?
|
| Radiography | 2 | 2010 | 572 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2007 | 369 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2000 | 3259 | 0.050 |
Why?
|
| Hysterosalpingography | 2 | 1999 | 2 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2015 | 3705 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2000 | 3187 | 0.040 |
Why?
|
| Infertility, Female | 1 | 1999 | 25 | 0.040 |
Why?
|
| Urography | 1 | 1998 | 21 | 0.040 |
Why?
|
| Toxoplasmosis | 1 | 1997 | 13 | 0.040 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1997 | 85 | 0.040 |
Why?
|
| Sphincter of Oddi | 1 | 1997 | 51 | 0.040 |
Why?
|
| Pancreatic Ducts | 1 | 1997 | 76 | 0.040 |
Why?
|
| Colitis | 1 | 1997 | 156 | 0.030 |
Why?
|
| Child | 2 | 2000 | 6405 | 0.030 |
Why?
|
| Angiomyolipoma | 1 | 1995 | 4 | 0.030 |
Why?
|
| Teratoma | 1 | 1995 | 22 | 0.030 |
Why?
|
| Testicular Neoplasms | 1 | 1995 | 27 | 0.030 |
Why?
|
| Pancreatitis | 1 | 1997 | 279 | 0.030 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 1994 | 25 | 0.030 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1997 | 348 | 0.030 |
Why?
|
| Renal Insufficiency | 1 | 1995 | 121 | 0.030 |
Why?
|
| Random Allocation | 1 | 2015 | 442 | 0.030 |
Why?
|
| Diabetic Nephropathies | 1 | 1995 | 161 | 0.030 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 148 | 0.030 |
Why?
|
| Pregnancy | 1 | 1999 | 2334 | 0.030 |
Why?
|
| Mediastinal Neoplasms | 1 | 1991 | 27 | 0.020 |
Why?
|
| Ascites | 1 | 1991 | 38 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 4848 | 0.020 |
Why?
|
| Drug Hypersensitivity | 1 | 1991 | 35 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1991 | 215 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1995 | 529 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2000 | 7277 | 0.020 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 1990 | 6 | 0.020 |
Why?
|
| Fallopian Tubes | 1 | 1990 | 11 | 0.020 |
Why?
|
| Polyps | 1 | 1990 | 12 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2015 | 657 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2010 | 136 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2008 | 42 | 0.020 |
Why?
|
| Empyema | 1 | 1988 | 6 | 0.020 |
Why?
|
| Hydrothorax | 1 | 1988 | 7 | 0.020 |
Why?
|
| Hernia, Inguinal | 1 | 1988 | 21 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 2008 | 109 | 0.020 |
Why?
|
| Bronchi | 1 | 1988 | 59 | 0.020 |
Why?
|
| Pneumothorax | 1 | 1988 | 42 | 0.020 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1988 | 48 | 0.020 |
Why?
|
| Adolescent | 1 | 2000 | 8912 | 0.020 |
Why?
|
| Foreign Bodies | 1 | 1988 | 58 | 0.020 |
Why?
|
| Taxoids | 1 | 2007 | 41 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2007 | 83 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2007 | 104 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2007 | 349 | 0.020 |
Why?
|
| Enteral Nutrition | 1 | 1988 | 157 | 0.020 |
Why?
|
| Diverticulum | 1 | 2006 | 29 | 0.020 |
Why?
|
| Time Factors | 1 | 1994 | 4655 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2006 | 114 | 0.020 |
Why?
|
| Nephrectomy | 1 | 2004 | 103 | 0.010 |
Why?
|
| Risk Factors | 2 | 2008 | 5731 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 948 | 0.010 |
Why?
|
| Toxoplasma | 1 | 1997 | 23 | 0.010 |
Why?
|
| United States | 1 | 2010 | 7367 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1997 | 242 | 0.010 |
Why?
|
| Pressure | 1 | 1997 | 252 | 0.010 |
Why?
|
| Reference Values | 1 | 1997 | 579 | 0.010 |
Why?
|
| Manometry | 1 | 1997 | 276 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1997 | 546 | 0.010 |
Why?
|
| Acute Disease | 1 | 1997 | 658 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 1174 | 0.010 |
Why?
|
| Endoscopy | 1 | 1997 | 464 | 0.010 |
Why?
|
| Incidence | 1 | 1997 | 1603 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1995 | 453 | 0.010 |
Why?
|
| Testicular Hydrocele | 1 | 1991 | 3 | 0.010 |
Why?
|
| Thorax | 1 | 1991 | 49 | 0.010 |
Why?
|
| Cohort Studies | 1 | 1997 | 2358 | 0.010 |
Why?
|
| Infant | 1 | 1995 | 2891 | 0.000 |
Why?
|
| Silicones | 1 | 1988 | 32 | 0.000 |
Why?
|
| Animals | 1 | 1997 | 20881 | 0.000 |
Why?
|